BI
Insider
Broadwood Capital Inc
10% ownerBroadwood Capital Inc (10% owner) filed 6 Form 4 reports as a reporting entity in the past 24 months (6 purchases, 0 sales), most often in STAA. Across 5 priced purchase filings, the average 21-session return was -1.2% from execution and -4.5% from disclosure (delay-adjusted; derived). The largest single filing was $11.2M of STAA (661,961 sh across 5 lots, as filed), executed Feb 27 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-1.2%
avg across 5 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-4.5%
same 5 filings, from disclosure
Filings, ttm
6
6 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$23.5M
shares × price, as filed
Last traded
Mar 25 2025
Filed Mar 25 2025
Volume by month
Buys $23.5M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
6 filings
Sector per market data · by filing · past 24 months
Most traded names
STAA
STAA
STAA · 5 buys · 0 sells
5 filings
OCX
OCX
OCX · 1 buy · 0 sells
1 filing
Recent filings
STAAPURCHASE
STAAR SURGICAL CO
View filing →
$2.4M136,696 sh across 2 lots
Exec Mar 21 2025
Filed Mar 25 2025 · 5:30 PM ET STAAPURCHASE STAAR SURGICAL CO View filing → $3.6M
201,844 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET STAAPURCHASE STAAR SURGICAL CO View filing → $482K
27,953 sh across 2 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET STAAPURCHASE STAAR SURGICAL CO View filing → $11.2M
661,961 sh across 5 lots
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET STAAPURCHASE STAAR SURGICAL CO View filing → $1.9M
76,500 sh across 3 lots
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET OCXPURCHASE Oncocyte Corp View filing → $3.9M
1,315,339 sh × $2.95
Exec Oct 2 2024
Filed Oct 4 2024 · 5:30 PM ET